Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Apoptosi
2026-06-15
Explore advanced applications of the Protease Inhibitor Cocktail EDTA-Free in preserving protein integrity for apoptosis and phosphorylation analysis. This article uniquely bridges mechanistic insights from recent leukemia research to practical proteome workflows.
-
KPT-330 (Selinexor) in Cancer Research: Nuclear Export and B
2026-06-15
Explore how KPT-330 (Selinexor), a selective CRM1 inhibitor, advances cancer research through targeted nuclear export inhibition and synergistic therapy approaches. This article offers a deeper, evidence-based analysis of Selinexor’s mechanisms, experimental protocols, and translational potential.
-
AT13387: Precision Hsp90 Inhibitor Workflows in Cancer Biolo
2026-06-14
AT13387, a potent Hsp90 inhibitor from APExBIO, enables reliable, nanomolar-level disruption of oncogenic signaling and apoptosis induction in cancer biology research. This article details advanced experimental workflows, troubleshooting strategies, and key cross-domain insights inspired by recent breakthroughs in regulated cell death.
-
U 46619 Applications: Platelet Aggregation and Vascular Mode
2026-06-13
U 46619 (11,9 epoxymethano-prostaglandin H2) enables highly reproducible platelet aggregation, vascular tone, and renal response studies. Explore advanced workflows, protocol optimizations, and troubleshooting strategies that maximize the reliability of this selective TP receptor agonist from APExBIO.
-
α-Linolenic Acid: Structure, Mechanism, and Research Utility
2026-06-12
α-Linolenic Acid (ALA) is an essential omega-3 fatty acid, indispensable for lipid metabolism and widely used in cardiovascular, inflammatory, and cancer biology research. This article details ALA’s biochemical properties, mechanistic pathways, and protocol integration, distinguishing verified applications from common misconceptions.
-
Merbromin: Applied Protocols for Fluorescence and Enzyme Ass
2026-06-12
Merbromin stands out as a dual-purpose tool—serving as both a protein–ligand interaction probe and an enzyme inhibition assay reagent. This article translates the latest research into actionable protocols, troubleshooting insights, and comparative guidance for researchers aiming to leverage Merbromin’s unique properties in biochemical and diagnostic workflows.
-
URB597 (KDS-4103): Enhancing Endocannabinoid Pain Research
2026-06-11
URB597 (KDS-4103) empowers researchers to probe and modulate the endocannabinoid system with high selectivity, driving robust models of pain, neuroinflammation, and neuroplasticity. This article provides actionable workflows, troubleshooting insights, and a synthesis of breakthroughs from novel orofacial pain studies, positioning URB597 as an essential tool for translational neuroscience.
-
Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research
2026-06-11
Rotigotine stands out as a benchmark dopamine D2/D3 receptor agonist for translational Parkinson’s disease research, enabling robust modeling and reliable neuroprotection assays. With precise protocol parameters and validated stability methods, APExBIO’s Rotigotine empowers reproducibility even in challenging in vitro and in vivo workflows.
-
Homoharringtonine: Mechanistic Insights for Oncology and Ant
2026-06-10
Explore how Homoharringtonine, a cytotoxic alkaloid, redefines research in both leukemia and SARS-CoV-2 antiviral fields by targeting protein synthesis at the ribosomal level. This article provides an advanced mechanistic analysis and protocol considerations that set it apart from prior reviews.
-
Optimizing Mucin and Chondrogenic Staining: Alcian Blue & Nu
2026-06-10
This article addresses persistent laboratory challenges in mucopolysaccharide and chondrogenic differentiation assays, providing evidence-based guidance for researchers using the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 (SKU K1188). Integrating scenario-driven Q&A with protocol insights, it distills best practices for reproducible, high-contrast histological staining with this dual-staining kit.
-
Applied Workflows with EZ Cap™ Cre mRNA (m1Ψ) for Gene Editi
2026-06-09
EZ Cap™ Cre mRNA (m1Ψ) enables efficient, low-immunogenicity Cre recombinase expression for advanced gene editing workflows. Its stability and translational design streamline in vitro and in vivo applications, especially when paired with next-generation delivery systems.
-
Myeloid TET2-IL-1β Axis Restricts EC Cell Differentiation in
2026-06-09
This study uncovers a neuro-immune-epithelial circuit in intestinal inflammation, showing that myeloid-specific TET2 loss protects against colitis by elevating IL-1β, which disrupts catecholaminergic stimulation of enterochromaffin (EC) cell differentiation. These findings advance understanding of how stress and immune signaling converge to shape gut epithelial responses and inflammation.
-
HOBt (1-Hydroxybenzotriazole) in Precision Peptide Synthesis
2026-06-08
HOBt (1-Hydroxybenzotriazole) is a gold-standard racemization inhibitor, empowering chemists to achieve high-fidelity amide bond formation and minimize epimerization in both peptide synthesis and advanced drug design. This article details practical workflows, troubleshooting, and innovations based on recent literature and APExBIO’s high-purity offering.
-
SC 79: Redefining Akt Activation for Translational Neuroprot
2026-06-08
This thought-leadership article explores the mechanistic and strategic advances unlocked by SC 79, a potent and cytosol-specific Akt activator, for translational researchers in neuroscience and beyond. By dissecting the unique activation profile of SC 79, its implications in neuroprotection, and lessons from recent AKT-centric studies, we chart new directions for the field and provide actionable guidance for experimental design.
-
Spatially Targeted mTORC1 Inhibition Uncovers Nuclear Transc
2026-06-07
The reference paper introduces TerminaTOR, a genetically encoded tool that enables precise, subcellular inhibition of mTORC1, revealing distinct nuclear functions in transcriptional regulation. This spatially resolved approach advances understanding of mTORC1 compartmentalization and opens new avenues for dissecting the PI3K/Akt/mTOR pathway's role in gene expression.